ISPC vs WELL · rev $9.3M vs P/E 100, rev $10.84B
iSpecimen Inc (ISPC) versus Welltower Inc (WELL) — a side-by-side from cached financials, not a winner call.
iSpecimen Inc (ISPC) is a diagnostics & research company listed on US.
Welltower Inc (WELL) is a reit - healthcare facilities company listed on NYSE.
Latest reported ISPC revenue for 2024-12-31 was $9.3M. Net income was -$12.5M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ISPC currently screens at market cap $4.4M.
Latest reported WELL revenue for 2025-12-31 was $10.84B. Net income was $936.8M. Revenue was up 35.6% from 2024-12-31 to 2025-12-31. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
ISPC currently screens at market cap $4.4M. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
Not investment advice. Open the ISPC and WELL stock pages for the full models.
Not investment advice.